What drugs does EDENBRIDGE PHARMS make?

EDENBRIDGE PHARMS has 12 FDA-approved drugs including YARGESA, ZUBSOLV.

What therapeutic areas does EDENBRIDGE PHARMS focus on?

EDENBRIDGE PHARMS focuses primarily on Cardiovascular.

← Back

Data updated: Mar 10, 2026

EDENBRIDGE PHARMS

Cardiovascular

Specialty

EDENBRIDGE PHARMS is a specialty pharmaceutical company focused on Cardiovascular. Key products include ZUBSOLV.

2013

Since

Drugs

Trials

Approved (2yr)

Key Drugs

YARGESA

miglustat

Rare Disease

Glucosylceramide synthase 1 indications · 2020

ZUBSOLV

buprenorphine hydrochloride

Kappa-opioid receptor 1 indications · 2013

Recent Activity

DILTIAZEM HYDROCHLORIDE 2026-02-23

Labeling

DILTIAZEM HYDROCHLORIDE 2026-02-23

Labeling

DILTIAZEM HYDROCHLORIDE 2026-01-24

Labeling

DILTIAZEM HYDROCHLORIDE 2026-01-24

Labeling

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE 2026-01-21

DILTIAZEM HYDROCHLORIDE 2026-01-18

Labeling

LOPERAMIDE HYDROCHLORIDE 2025-12-29

ZUBSOLV 2025-12-22

Labeling

LOPERAMIDE HYDROCHLORIDE 2025-11-17

DILTIAZEM HYDROCHLORIDE 2025-11-14

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 100%

2 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Johnson & Johnson big-pharma

Cardiovascular

Bayer big-pharma

Cardiovascular

EDENBRIDGE PHARMS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (12)

Active (6)

Discontinued (6)

Company Info